JASMINE TORREY: Open Payments
NPI 1912617317 · SALEM, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 15 payments from 8 companies in 2025. Trend: 2023 $46 · 2024 $245 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $121 |
| Endo USA, Inc. | 2 | $49 |
| Amgen Inc. | 2 | $44 |
| Bioventus LLC | 1 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Smith+Nephew, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| Sandoz Inc. | 1 | $20 |
Products named: JOURNAVX, XIAFLEX, EXOGEN ULTRASOUND BONE HEALING SYSTEM, ORENCIA, EVOS, ENBREL, Actemra, TAVNEOS.
Industry payments across NH — which companies pay providers there.
